About PEP-Therapy

Website
Website
Employees
Employees
1-10 employees View all
Industry
Industry
Biotechnology
Location
Location
29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR
Description
Information
PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.

PEP-Therapy Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about PEP-Therapy

What is PEP-Therapy email format?

The widely used PEP-Therapy email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is PEP-Therapy customer service number?

To contact PEP-Therapy customer service number in your country click here to find.


Who is the CEO of PEP-Therapy?

Antoine Prestat is the CEO of PEP-Therapy. To contact Antoine Prestat email at [email protected] or [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more